[Bio USA] Lotte Biologics eyes more CDMO orders with Songdo Plant 1

SAN DIEGO -- Lotte Biologics is zeroing in on securing more orders and expanding its global presence with the completion of Plant 1’s construction and approval for use at its Songdo Bio Campus in Incheon.

“Lotte Biologics has now secured a dual-site production system in the United States and Korea,” said James Park, CEO of Lotte Biologics, in a press conference held on the sidelines of the BIO International Convention in San Diego on Tuesday.

“Based on the Songdo Bio Campus’ Plant 1 and the Syra ...